PDL Biopharma
PDLI
#8100
Rank
โ‚น26.14 B
Marketcap
โ‚น228.89
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Revenue for PDL Biopharma (PDLI)

Revenue in 2020 (TTM): โ‚น5.77 Billion

According to PDL Biopharma 's latest financial reports the company's current revenue is โ‚น7.47 Billion. In 2018 the company made a revenue of โ‚น18.14 Billion a decrease over the revenue in the year 2017 that were of โ‚น28.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PDL Biopharma from 2001 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚น5.77 B
2018โ‚น18.14 B-35.24%
2017โ‚น28.01 B41.34%
2016โ‚น19.82 B-61.41%
2015โ‚น51.36 B1.67%
2014โ‚น50.51 B23.08%
2013โ‚น41.04 B18.26%
2012โ‚น34.70 B3.45%
2011โ‚น33.55 B4.95%
2010โ‚น31.96 B8.42%
2009โ‚น29.48 B8.13%
2008โ‚น27.27 B
2006โ‚น38.36 B48.05%
2005โ‚น25.91 B191.23%
2004โ‚น8.89 B32.84%
2003โ‚น6.69 B53.73%
2002โ‚น4.35 B5.97%
2001โ‚น4.11 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
โ‚น6.040 T 80,749.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.405 T 45,486.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น3.04 B-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น0.63 B-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
โ‚น5.11 B-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA